Furthermore, we assessed to what extent individual abnormal clinical findings (overweight/obesity, central obesity, hypertension, on blood pressure treatment, history of infertility treatment, actual hormonal contraceptive use, the presence of trombophilic gene mutations, actual smoking status, aberrant serum levels of total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, lipoprotein A, CRP, and uric acid, and increased plasma levels of homocysteine) might influence already present aberrant microRNA expression profiles in mothers after complicated pregnancies. The gene discussed is CRP; the disease is Abdominal obesity.